| USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 80.39B | 79.24B | 77.65B | 71.89B | 69.69B |
| YoY Growth | +1.5% | +2.0% | +8.0% | +3.2% | — |
| Gross Profit | 22.26B | 22.05B | 21.76B | 20.72B | 20.41B |
| Gross Margin | 27.7% | 27.8% | 28.0% | 28.8% | 29.3% |
| R&D | — | — | — | — | — |
| SG&A | 20.61B | 19.93B | 19.60B | 18.30B | 18.84B |
| EBIT | 1.58B | 2.08B | 2.39B | 2.56B | 1.66B |
| EBIT Margin | 2.0% | 2.6% | 3.1% | 3.6% | 2.4% |
| D&A | 2.50B | 2.44B | 2.46B | 2.31B | 2.12B |
| EBITDA | 4.08B | 4.53B | 4.85B | 4.87B | 3.78B |
| EBITDA Margin | 5.1% | 5.7% | 6.2% | 6.8% | 5.4% |
| Net Income | 958.60M | 1.30B | 1.51B | 1.62B | 850.20M |
| Net Margin | 1.2% | 1.6% | 1.9% | 2.3% | 1.2% |
| EPS (diluted) | $1.64 | $2.23 | $2.27 | $2.70 | $1.47 |
| Shares (dil., M) | 584 | 581 | 534 | 475 | 578 |
Company Brief
Albertsons Companies, Inc., through its subsidiaries, engages in the operation of food and drug stores in the United States. The company's food and drug retail stores offer grocery products, general merchandise, health and beauty care products, pharmacy, fuel, and other items and services. It also manufactures and processes food products for sale in stores. As of February 26, 2022, it operated 2,276 stores under various banners, including Albertsons, Safeway, Vons, Pavilions, Randalls, Tom Thumb, Carrs, Jewel-Osco, Acme, Shaw's, Star Market, United Supermarkets, Market Street, Haggen, Kings Food Markets, and Balducci's Food Lovers Market; and 1,722 pharmacies, 1,317 in-store branded coffee shops, 402 adjacent fuel centers, 22 distribution centers, and 20 manufacturing facilities, as well as various digital platforms. The company was founded in 1860 and is headquartered in Boise, Idaho.
| Gross Margin | 27.2% |
| EBITDA Margin | 5.1% |
| EBIT Margin | 1.9% |
| Net Margin | 1.1% |
| FCF Margin | 0.9% |
| ROE | 28.5% |
| ROIC | 5.7% |
| ROA | 3.2% |
| ROCE | 7.8% |
| Asset Turnover | 3.02× |
| ROIC | 5.7% |
| ROE | 28.5% |
| ROA | 3.2% |
| ROCE | 7.8% |
| Asset Turnover | 3.02× |
| FCF Margin | 0.9% |
| Net Margin | 1.1% |
| Insider buys (12m) | — |
| Insider sells (12m) | — |
| Float | 64.4% |
| Shares Out. | 549.3M |
| Mean Target | $20.88 |
| Median Target | $21.50 |
| High Target | $29 |
| Low Target | $14 |
| vs. Mean | +21.8% |
| Buy / Hold / Sell | — |
| Cash & ST Invest. | $339.2M |
| Total Debt | $14.2B |
| Net Cash / (Debt) | -$13.9B |
| Total Assets | $29.3B |
| Total Equity | $3.4B |
| Goodwill & Intang. | $3.5B |
| Tangible Book/sh | $-1.71 |
| Current Ratio | 0.91× |
| Quick Ratio | 0.20× |
| D/E Ratio | 6.17× |
| Debt / Assets | 57.0% |
| Net Debt / EBITDA | 3.67× |
| Interest Coverage | 3.25× |
| Beta (5yr) | 0.25 |
| Revenue 1yr | +1.5% |
| Revenue 3yr | +3.8% |
| Revenue 5yr | +3.6% |
| EPS 1yr | -26.5% |
| EPS 3yr | -15.3% |
| EPS 5yr | +2.8% |
| FCF 5yr | -24.2% |
| Dividend 5yr | -7.4% |
| Annual DPS | $0.60 |
| Yield (fwd) | 3.50% |
| Payout Ratio | 38.3% |
| Ex-div Date | 2026-01-23 |
| Pay Date | 2026-02-06 |
| Capex | $1.9B |
| Capex / Revenue | 2.4% |
| SBC | $106.2M |
| Dividends Paid | $295.1M |
| Buybacks | $82.5M |
| Gross Margin | 27.2% |
| EBITDA Margin | 5.1% |
| EBIT Margin | 1.9% |
| Net Margin | 1.1% |
| FCF Margin | 0.9% |
| ROE | 28.5% |
| ROIC | 5.7% |
| ROA | 3.2% |
| ROCE | 7.8% |
| Asset Turnover | 3.02× |
| ROIC | 5.7% |
| ROE | 28.5% |
| ROA | 3.2% |
| ROCE | 7.8% |
| Asset Turnover | 3.02× |
| FCF Margin | 0.9% |
| Net Margin | 1.1% |
| Insider buys (12m) | — |
| Insider sells (12m) | — |
| Float | 64.4% |
| Shares Out. | 549.3M |
| Mean Target | $20.88 |
| Median Target | $21.50 |
| High Target | $29 |
| Low Target | $14 |
| vs. Mean | +21.8% |
| Buy / Hold / Sell | — |
| USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 80.39B | 79.24B | 77.65B | 71.89B | 69.69B |
| YoY Growth | +1.5% | +2.0% | +8.0% | +3.2% | — |
| Gross Profit | 22.26B | 22.05B | 21.76B | 20.72B | 20.41B |
| Gross Margin | 27.7% | 27.8% | 28.0% | 28.8% | 29.3% |
| R&D | — | — | — | — | — |
| SG&A | 20.61B | 19.93B | 19.60B | 18.30B | 18.84B |
| EBIT | 1.58B | 2.08B | 2.39B | 2.56B | 1.66B |
| EBIT Margin | 2.0% | 2.6% | 3.1% | 3.6% | 2.4% |
| D&A | 2.50B | 2.44B | 2.46B | 2.31B | 2.12B |
| EBITDA | 4.08B | 4.53B | 4.85B | 4.87B | 3.78B |
| EBITDA Margin | 5.1% | 5.7% | 6.2% | 6.8% | 5.4% |
| Net Income | 958.60M | 1.30B | 1.51B | 1.62B | 850.20M |
| Net Margin | 1.2% | 1.6% | 1.9% | 2.3% | 1.2% |
| EPS (diluted) | $1.64 | $2.23 | $2.27 | $2.70 | $1.47 |
| Shares (dil., M) | 584 | 581 | 534 | 475 | 578 |
Company Brief
Albertsons Companies, Inc., through its subsidiaries, engages in the operation of food and drug stores in the United States. The company's food and drug retail stores offer grocery products, general merchandise, health and beauty care products, pharmacy, fuel, and other items and services. It also manufactures and processes food products for sale in stores. As of February 26, 2022, it operated 2,276 stores under various banners, including Albertsons, Safeway, Vons, Pavilions, Randalls, Tom Thumb, Carrs, Jewel-Osco, Acme, Shaw's, Star Market, United Supermarkets, Market Street, Haggen, Kings Food Markets, and Balducci's Food Lovers Market; and 1,722 pharmacies, 1,317 in-store branded coffee shops, 402 adjacent fuel centers, 22 distribution centers, and 20 manufacturing facilities, as well as various digital platforms. The company was founded in 1860 and is headquartered in Boise, Idaho.
| Cash & ST Invest. | $339.2M |
| Total Debt | $14.2B |
| Net Cash / (Debt) | -$13.9B |
| Total Assets | $29.3B |
| Total Equity | $3.4B |
| Goodwill & Intang. | $3.5B |
| Tangible Book/sh | $-1.71 |
| Current Ratio | 0.91× |
| Quick Ratio | 0.20× |
| D/E Ratio | 6.17× |
| Debt / Assets | 57.0% |
| Net Debt / EBITDA | 3.67× |
| Interest Coverage | 3.25× |
| Beta (5yr) | 0.25 |
| Revenue 1yr | +1.5% |
| Revenue 3yr | +3.8% |
| Revenue 5yr | +3.6% |
| EPS 1yr | -26.5% |
| EPS 3yr | -15.3% |
| EPS 5yr | +2.8% |
| FCF 5yr | -24.2% |
| Dividend 5yr | -7.4% |
| Annual DPS | $0.60 |
| Yield (fwd) | 3.50% |
| Payout Ratio | 38.3% |
| Ex-div Date | 2026-01-23 |
| Pay Date | 2026-02-06 |
| Capex | $1.9B |
| Capex / Revenue | 2.4% |
| SBC | $106.2M |
| Dividends Paid | $295.1M |
| Buybacks | $82.5M |